← Browse by Condition
Medical Condition

secondary hemophagocytic lymphohistiocytosis shlh

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2, Phase 3

ClinicalMetric aggregates all active clinical trials for secondary hemophagocytic lymphohistiocytosis shlh from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries. Trials are updated daily as new studies open, status changes, and enrollment targets are updated.

  • Recruiting trials — currently enrolling participants, with eligibility criteria
  • Phase 1–4 studies — from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary for every trial listing
NCT05416307 Phase 2, Phase 3
Recruiting

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

Enrollment
156 pts
Location
United States, Austr...
Sponsor
Electra Therapeutics Inc.
View Trial →